Michael W. Hofmann

Health Technology

Consumer Services

Profile

Michael W.
Hofmann worked as the Chief Executive Officer at X2-Pharma GmbH and as the Director of Biological Research at Alantos Pharmaceuticals Holding, Inc. Prior to that, he held Principal positions at Ruprecht-Karls-Universität Heidelberg, the University of Mannheim, and BioReliance Manufacturing GmbH.
Hofmann earned a doctorate degree from Ruprecht-Karls-Universität Heidelberg.

Former positions of Michael W. Hofmann

Companies	Position	End
BioReliance Manufacturing GmbH	Corporate Officer/Principal	-
University of Mannheim	Corporate Officer/Principal	-
X2-Pharma GmbH X2-Pharma GmbH Pharmaceuticals: MajorHealth Technology X2-Pharma GmbH develops pharmaceutical products for the treatment of inflammatory diseases. It is a biopharmaceutical company that offers small molecule pharmaceuticals for the treatment of inflammatory diseases. The company is headquartered in Heidelberg, Germany.	Corporate Officer/Principal	-
Ruprecht-Karls-Universität Heidelberg	Corporate Officer/Principal	-
Alantos Pharmaceuticals Holding, Inc. Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA.	Corporate Officer/Principal	-

See the detail of Michael W. Hofmann's experience

Training of Michael W. Hofmann

Ruprecht-Karls-Universität Heidelberg

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies